Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2003;56:831-834; doi:10.1136/jcp.56.11.831
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2003;56:831-834
© 2003 BMJ Publishing Group Ltd & Association of Clinical Pathologists

ORIGINAL ARTICLE

Prognostic relevance of rosette-like features in osteosarcoma

K Okada1, T Hasegawa2, R Yokoyama3, Y Beppu3, E Itoi1

1 Department of Orthopaedic Surgery, Akita University School of Medicine, Akita 010-8543, Japan
2 Pathology Division, National Cancer Centre Research Institute, Tokyo 104-0045, Japan
3 Orthopaedic Divisions, National Cancer Centre Research Institute and Hospital, Tokyo 104-0045, Japan

Correspondence to:
Correspondence to:
Dr K Okada
MD, Department of Orthopaedic Surgery, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan; cshokada{at}med.akita-u.ac.jp

Aims: To clarify the prognostic relevance of rosette-like features and other clinicopathological and immunohistochemical variables in patients with osteosarcoma.

Methods: Clinicopathological and immunohistochemical variables were analysed in 131 patients with non-metastatic high grade conventional osteosarcoma, with particular attention to the prognostic impact of rosette-like features.

Results: Rosette-like features were present in 18 (14%) cases. Rosette-like features were significantly associated with the osteoblastic subtype, numerous osteoclast-like giant cells, moderate pleomorphism, frequent haemangiopericytoma-like vascular patterns, epithelioid cytological features, positive immunoreactivity for epithelial membrane antigen and CD56, and negative staining for cytokeratin. In a multivariate analysis, rosette-like features (relative risk (RR), 3.8), a poor chemotherapy effect (RR, 2.9), and a tumour size of 10 cm or more (RR, 2.8) were identified as unfavourable prognostic factors.

Conclusions: Rosette-like features can easily be identified from routine histological slides and the relative risk in patients with non-metastatic, conventional osteosarcoma is as high as other well known prognostic factors, including large size and poor chemotherapy effect.

Keywords: osteosarcoma; rosette; chemotherapy; prognosis

Abbreviations: EMA, epithelial membrane antigen; RR, relative risk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Kouno, T., Watanabe, T., Umeda, T., Beppu, Y., Kojima, R., Sungwon, K., Kobayashi, Y., Tobinai, K., Hasegawa, T., Matsuno, Y. (2005). CD56-positive Small Round Cell Tumor: Osseous Plasmacytoma Manifested in Osteolytic Tumors of the Iliac Bone and Femora. Jpn J Clin Oncol 35: 90-93 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs